Oticon More vs Otofonix Encore

The Oticon More is a premium prescription behind-the-ear hearing aid that earns an A grade with a SoundScore of 4.6/5 in our lab testing, placing it in the top 23% of the 39 prescription hearing aids we've evaluated. Currently available at $4,598, this 2021 release has earned our Expert's Choice Award in both 2023 and 2024. In our testing, the Oticon More demonstrates strong speech clarity performance. Speech in quiet scores 4.0/5, which is 0.65 points above the category average—a meaningful advantage for everyday conversation. Speech in noise measures 2.7/5, which is 0.60 points above the category average, though the absolute score reflects the inherent challenge all hearing aids face in noisy environments. Own-voice comfort is solid at 3.1/5, sitting 0.40 points above average. The device does show one notable weakness: feedback handling scores 3.5/5, which is 1.22 points below the category average of 4.72/5. While this is still a solid score in absolute terms, competing devices in this price range generally perform better in this area. Music streaming is solid at 3.0/5, slightly above the category average. The Oticon More offers flexibility with both rechargeable and disposable battery options, plus streaming compatibility with both iPhone and Android devices including hands-free calling. For those considering alternatives, newer models like the Oticon Intent and Oticon Real score higher in our testing at similar price points. The Oticon More remains a capable choice for listeners who prioritize speech clarity and want a well-established platform with proven performance.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.